-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CWa2RuDCXx1YEvQF1/SlZ/qZhjtaDcC/afqVyFlLZgWu/lrDnpunW7KFtJu1IYuO d6Kg+6lM1n0yEmuuChxV7g== 0000912057-97-005110.txt : 19970222 0000912057-97-005110.hdr.sgml : 19970222 ACCESSION NUMBER: 0000912057-97-005110 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19970213 SROS: NASD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MOLECULAR DEVICES CORP CENTRAL INDEX KEY: 0001003113 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 942914362 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-44597 FILM NUMBER: 97531553 BUSINESS ADDRESS: STREET 1: 1311 ORLEANS DR CITY: SUNNYVALE STATE: CA ZIP: 94089 BUSINESS PHONE: 4087471700 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BOWMAN A BLAINE CENTRAL INDEX KEY: 0001008891 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 1228 TITAN WAY CITY: SUNNYVALE STATE: CA ZIP: 94086 BUSINESS PHONE: 4087471700 MAIL ADDRESS: STREET 1: MOLECULAR DEVICES CORP STREET 2: 1311 ORLEANS DRIVE CITY: SUNNYVALE STATE: CA ZIP: 94089 SC 13G/A 1 SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* Molecular Devices Corporation ---------------------------------- (Name of Issuer) Common ---------------------------------- (Title of Class of Securities) 60851C107 ---------------------------------- (CUSIP Number) Check the following box if a fee is being paid with this statement / /. (A fee is not required only if the filing person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7.) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 5 Pages CUSIP No. 60851C107 13G Page 2 of 5 Pages --------- --- --- - ------------------------------------------------------------------------------- (1) Names of Reporting Persons. S.S. or I.R.S. Identification Nos. of Above Persons A. Blaine Bowman - ------------------------------------------------------------------------------- (2) Check the Appropriate Box if a Member (a) / / of a Group* (b) /X/ - ------------------------------------------------------------------------------- (3) SEC Use Only - ------------------------------------------------------------------------------- (4) Citizenship or Place of Organization United States - ------------------------------------------------------------------------------- Number of Shares (5) Sole Voting Beneficially Power 82,499 Owned by -------------------------------------------------- Each Reporting (6) Shared Voting Person With Power 382,166 (see disclaimer of beneficial ownership in response to Item #4) -------------------------------------------------- (7) Sole Dispositive Power 82,499 -------------------------------------------------- (8) Shared Dispositive Power 382,166 (see disclaimer of beneficial ownership in response to Item #4) - ------------------------------------------------------------------------------- (9) Aggregate Amount Beneficially Owned by Each Reporting Person 464,665 - ------------------------------------------------------------------------------- (10) Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares* - ------------------------------------------------------------------------------- (11) Percent of Class Represented by Amount in Row (9) 5.2% - ------------------------------------------------------------------------------- (12) Type of Reporting Person* IN - ------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT! Page 2 of 5 Pages ITEM 1(A). NAME OF ISSUER Molecular Devices - ------------------------------------------------------------------------------- ITEM 1(B). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES 1311 Orleans Drive, Sunnyvale, CA - ------------------------------------------------------------------------------- ITEM 2(A). NAME OF PERSON(S) FILING A. Blaine Bowman - ------------------------------------------------------------------------------- ITEM 2(B). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE 1228 Titan Way, Sunnyvale, CA 94086 - ------------------------------------------------------------------------------- ITEM 2(C). CITIZENSHIP United States - ------------------------------------------------------------------------------- ITEM 2(D). TITLE OF CLASS OF SECURITIES Common - ------------------------------------------------------------------------------- ITEM 2(E). CUSIP NUMBER 60851C107 - ------------------------------------------------------------------------------- ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-1(b), OR 13d-2(b), CHECK WHETHER THE PERSON FILING IS A Not applicable. ITEM 4. OWNERSHIP (a) Amount Beneficially Owned: 464,665 --------------------------------------------------------------------------- (b) Percent of Class: 5.2% --------------------------------------------------------------------------- (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote 82,499* ----------------------------------------------------------------- (ii) shared power to vote or to direct the vote 382,166* ----------------------------------------------------------------- (iii) sole power to dispose or to direct the disposition of 82,499* ----------------------------------------------------------------- (iv) shared power to dispose or to direct the disposition of 382,166* ----------------------------------------------------------------- * Includes 382,166 shares beneficially owned by Dionex, of which Mr. Bowman, a director of the Company, is President, Chief Executive Officer and a director. Mr. Bowman disclaims beneficial ownership of the Dionex shares. Includes 25,499 shares that may be acquired within 60 days after December 31, 1996 pursuant to oustanding stock options. ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS Not applicable. - ------------------------------------------------------------------------------- Page 3 of 5 Pages ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON Not applicable. - ------------------------------------------------------------------------------- ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY Not applicable. - ------------------------------------------------------------------------------- ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP Not applicable. - ------------------------------------------------------------------------------- ITEM 9. NOTICE OF DISSOLUTION OF GROUP Not applicable. - ------------------------------------------------------------------------------- ITEM 10. CERTIFICATION Not applicable. - ------------------------------------------------------------------------------- Page 4 of 5 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. 2/14/97 ---------------------------------------- Date /s/ A. Blaine Bowman ---------------------------------------- Signature A. Blaine Bowman ---------------------------------------- (Name/Title) Page 5 of 5 Pages -----END PRIVACY-ENHANCED MESSAGE-----